CN1220169A - Artificial joint coated with bone morphogenesis protein and its making method - Google Patents

Artificial joint coated with bone morphogenesis protein and its making method Download PDF

Info

Publication number
CN1220169A
CN1220169A CN 98125674 CN98125674A CN1220169A CN 1220169 A CN1220169 A CN 1220169A CN 98125674 CN98125674 CN 98125674 CN 98125674 A CN98125674 A CN 98125674A CN 1220169 A CN1220169 A CN 1220169A
Authority
CN
China
Prior art keywords
artificial joint
morphogenetic protein
bone morphogenetic
hydroxyapatite
bone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 98125674
Other languages
Chinese (zh)
Other versions
CN1086591C (en
Inventor
孙福玉
李晓光
孙箭华
孟庆恩
宋玉珩
周蕙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Central Iron and Steel Research Institute
Original Assignee
Central Iron and Steel Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Central Iron and Steel Research Institute filed Critical Central Iron and Steel Research Institute
Priority to CN98125674A priority Critical patent/CN1086591C/en
Publication of CN1220169A publication Critical patent/CN1220169A/en
Application granted granted Critical
Publication of CN1086591C publication Critical patent/CN1086591C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention relates to an artificial joint coated with bone morphogenetic protein and its preparation method, belonging to the field of biomedical material. In particular, it is an artificial joint on which a layer of hydroxyapatite with thickness of 50-100 micrometers is sprayed, then a layer of bone morphogenetic protein is combined on the hydroxyapatite coating layer. The advantage of the artificial joint made up by adopting said invented method lies in that after the artificial joint is implanted in the human body, the physiological fixation of said artificial joint can be implemented by means of osteogenic effect induced by bone morphogenetic protein so as to effectively solve the difficult problem of that the existent artificial joint implanted in human body is easy to loosen.

Description

A kind of artificial joint and manufacture method thereof that scribbles bone morphogenetic protein
The present invention relates to field of biomedical materials, be applicable to that the physiology of artificial joint is fixed.
Artificial joint and functional prosthese implant significant to recovering limb function, and the artificial joint of annual implant into body has reached 1,200,000 examples, has obtained extensive clinical practice.But, the artificial joint that implants, some is improper because of performing the operation, and is fixing not good, and osteoporosis or activity take place loosening greatly, cause the prosthetic replacement to fail, and finally have to implement second operation.Implant the loosening problem in back in order to solve artificial joint, people have adopted at the artificial joint handle and have made the Margarita surface, increase contact surface with body internal skeleton and tissue, improve interface bond strength, in addition, filling bone cement carries out fixing (the seeing " idea that prevents the whole coxa substitution prosthetic loosening ", Chinese journal of orthopedics the 16th the 12nd phase of volume of December in 1996) of artificial joint etc.But these methods are not very effective.
The object of the present invention is to provide a kind of artificial joint and manufacture method thereof that scribbles bone morphogenetic protein, this artificial joint implants the back by the effect of bone morphogenetic protein induced osteogenesis, area of new bone is linked to each other with the body internal skeleton, the physiology of realization artificial joint is fixed, and solves effectively after artificial joint implants in the prior art loosening problem to take place.
Based on above-mentioned purpose, the characteristics in the artificial joint of the present invention are:
At artificial joint surface spraying one deck hydroxyapatite, thickness is 50-100 μ m, and then at hydroxyapatite coating layer surface recombination last layer bone morphogenetic protein, thickness is 0.1-1 μ m.
Above-mentioned artificial joint obtains by following production stage.
(1) process artificial joint with titanium-base alloy or vitallium,
(2) spraying one deck hydroxyapatite is stand-by on described artificial joint, and thickness is 50-100 μ m,
(3) add the phosphate buffer of 1-10% (percent by volume) 10mM in the carbamide of 5-7M, the control acid-base value is PH6-8,
(4) then bone morphogenetic protein is dissolved in the above-mentioned urea liquid, addition is the bone morphogenetic protein or 10 of 0.01-0.05mg/ml natural extract -5-10 -3The bone morphogenetic protein of mg/ml gene recombinaton forms the urea liquid that contains bone morphogenetic protein,
(5) will be coated with the artificial joint of hydroxyapatite surface coating again, put into the above-mentioned urea liquid that contains bone morphogenetic protein, soak 10-14 hour down at 20-30 ℃, every 2 hours slow agitating solution 1-3 minute, then with the artificial joint taking-up,
(6) be the artificial joint temperature of above-mentioned taking-up that 1-10 ℃, concentration are 85% the careful drip washing of alcoholic solution 2 times, the reuse temperature is that 1-10 ℃, concentration are 100% alcoholic solution drip washing one time, airing, aseptic preservation, stand-by, promptly make the artificial joint of the present invention.
BMP is the english abbreviation of bone morphogenetic protein (Bone Morphogenetic Protein).This albumen has unique induced osteogenesis function, and knochenbruch is connect fast again, lacks the quick Regeneration and Repair of bone, is with a wide range of applications at the orthopaedics and the department of stomatology.
At present, preparation BMP has two kinds of methods: a kind of is to utilize biochemical extraction method directly to extract from animal bone such as cattle, horse, pig, sheep, rabbit, Mus or osteosarcoma, and a kind of is to utilize method of gene recombination directly to prepare.The activation of the induced osteogenesis of the BMP of gene recombinaton is strong, than biochemical extraction method extract high by 10 3-10 6Doubly, though BMP has very strong induced osteogenesis activity, because of the absorption that implants, metabolism is fast, and action time is short.Be difficult to give full play to its induced osteogenesis effect.In addition, BMP does not have the support effect when reparation large scale bone is damaged.Therefore, BMP needs with some carrier material compound in clinical practice, himself obtains slow release and support so that make.
Hydroxyapatite (Hydroxyapatite is called for short HA) is a kind of of calcium orthophosphate base bioceramic, and its chemical formula is Ca 10(PO 4) 6(OH) 2Be that the main inanimate matter that constitutes bone and tooth, the back that implants can form chemical bond with bone and soft tissue on its surface.So have good biological activity and biocompatibility, be the ideal alternative repair materials of human body hard tissue (bone, tooth), be one of ideal carrier material of BMP.BMP and HA is compound, both helped giving full play to of BMP induced osteogenesis effect, the bone repair of HA is strengthened.
Artificial joint is processed by titanium-base alloy or vitallium usually, can obviously improve its biocompatibility at artificial joint surface spraying one deck hydroxyapatite.If at the compound BMP of hydroxyapatite surface, can realize that by its induced osteogenesis effect the physiology of artificial joint fixes.
Advantage of the present invention just is to use BMP induced osteogenesis effect, makes synosteosis in area of new bone and the body, realizes that the physiology of artificial joint is fixed, and solves the loosening problem after artificial joint is implanted effectively.
Embodiment
Do the animal contrast experiment with Canis familiaris L., two batches of hip joints have been prepared respectively, a collection of is the Margarita face joint that is not coated with bone morphogenetic protein, a collection of is the Margarita face joint that scribbles bone morphogenetic protein with the inventive method manufacturing, be installed on the Canis familiaris L. hipbone, after 3 months, the Margarita face recess that the dissection discovery does not contain the Margarita face joint of bone morphogenetic protein has only the 40-60% space to be filled by fibrous tissue; And the Margarita face recess that scribbles the joint of bone morphogenetic protein is all filled by the inductive area of new bone of BMP more than 95%.Show by animal experiment, owing to the induced osteogenesis effect of bone morphogenetic protein, can make the Margarita face recess of the quick filling Margarita of area of new bone face hip joint, and interconnect, effectively improve bond strength, prevent the loosening of joint with the body internal skeleton.

Claims (2)

1, a kind of artificial joint that scribbles bone morphogenetic protein, be characterised in that: at artificial joint surface spraying one deck hydroxyapatite, thickness is 50-100 μ m, and then at hydroxyapatite coating layer surface recombination last layer bone morphogenetic protein, thickness is 0.1-1 μ m.
2, the manufacture method of the described artificial joint of a kind of claim 1 is characterized in that: concrete production stage is as follows:
(1) process artificial joint with titanium-base alloy or vitallium,
(2) spraying one deck hydroxyapatite is stand-by on described artificial joint,
(3) add the phosphate buffer of 1-10% (percent by volume) 10mM in the carbamide of 5-7M, the control acid-base value is PH6-8,
(4) then bone morphogenetic protein is dissolved in the above-mentioned urea liquid, addition is the bone morphogenetic protein or 10 of 0.01-0.05mg/ml natural extract -5-10 -3The bone morphogenetic protein of mg/ml gene recombinaton forms the urea liquid that contains bone morphogenetic protein,
(5) will be coated with the artificial joint of hydroxyapatite surface coating again, put into the above-mentioned urea liquid that contains bone morphogenetic protein, soak 10-14 hour down at 20-30 ℃, every 2 hours slow agitating solution 1-3 minute, then with the artificial joint taking-up,
(6) be the artificial joint temperature of above-mentioned taking-up that 1-10 ℃, concentration are 85% the careful drip washing of alcoholic solution 2 times, the reuse temperature is that 1-10 ℃, concentration are 100% alcoholic solution drip washing one time, airing, aseptic preservation, stand-by, promptly make the artificial joint of the present invention.
CN98125674A 1998-12-21 1998-12-21 Artificial joint coated with bone morphogenesis protein and its making method Expired - Fee Related CN1086591C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN98125674A CN1086591C (en) 1998-12-21 1998-12-21 Artificial joint coated with bone morphogenesis protein and its making method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN98125674A CN1086591C (en) 1998-12-21 1998-12-21 Artificial joint coated with bone morphogenesis protein and its making method

Publications (2)

Publication Number Publication Date
CN1220169A true CN1220169A (en) 1999-06-23
CN1086591C CN1086591C (en) 2002-06-26

Family

ID=5229277

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98125674A Expired - Fee Related CN1086591C (en) 1998-12-21 1998-12-21 Artificial joint coated with bone morphogenesis protein and its making method

Country Status (1)

Country Link
CN (1) CN1086591C (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101732762A (en) * 2010-01-01 2010-06-16 东南大学 Bioactive artificial joint capable of slowly releasing trace element selenium
CN101721743B (en) * 2009-12-24 2012-09-05 曲彦隆 Method for strengthening joint stability by using rhBMP-2 release coating on surface of artificial joint
CN115068689A (en) * 2022-06-17 2022-09-20 北京邦塞科技有限公司 Bone filling capsular bag and preparation method and application thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1031040C (en) * 1989-11-16 1996-02-21 齐齐哈尔轻工学院 Biological active coating-Ti alloy man-made bone, joint and its preparation
CN2183774Y (en) * 1994-05-03 1994-11-30 北京京航生物医学工程公司 Artificial joint with hydroxy apatite surface
CN1081072C (en) * 1997-11-19 2002-03-20 华南理工大学 Method for preparing artificial joint with bio-active gradient coating

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101721743B (en) * 2009-12-24 2012-09-05 曲彦隆 Method for strengthening joint stability by using rhBMP-2 release coating on surface of artificial joint
CN101732762A (en) * 2010-01-01 2010-06-16 东南大学 Bioactive artificial joint capable of slowly releasing trace element selenium
CN101732762B (en) * 2010-01-01 2013-04-03 东南大学 Bioactive artificial joint capable of slowly releasing trace element selenium
CN115068689A (en) * 2022-06-17 2022-09-20 北京邦塞科技有限公司 Bone filling capsular bag and preparation method and application thereof
CN115068689B (en) * 2022-06-17 2024-01-19 北京邦塞科技有限公司 Bone filling bag, and preparation method and application thereof

Also Published As

Publication number Publication date
CN1086591C (en) 2002-06-26

Similar Documents

Publication Publication Date Title
LeGeros Properties of osteoconductive biomaterials: calcium phosphates.
Bloebaum et al. Retrieval analysis of a hydroxyapatite-coated hip prosthesis
Geesink et al. Bonding of bone to apatite-coated implants
US6478825B1 (en) Implant, method of making same and use of the implant for the treatment of bone defects
Simske et al. Porous materials for bone engineering
US10478525B2 (en) Process for demineralization of bone matrix with preservation of natural growth factors
DE69333878T2 (en) PROSTHESIS WITH INCREASED OSTEOUS PROPERTIES
US5947893A (en) Method of making a porous prothesis with biodegradable coatings
US8690874B2 (en) Composition and process for bone growth and repair
EP3338818B1 (en) Bone repair reusable composite material based on acellular biological tissue matrix material and preparation method therefor
JPH08332217A (en) Improved method for fixing implant
JPS6162466A (en) Collagen coated bone implant piece
US6998135B1 (en) Demineralized corticocancellous bone sheet
EP3589334A1 (en) Process for instant nanoporous bioartificial bone tissue composite engineering
JP2761339B2 (en) Novel surface coating for prosthetic devices and prosthetic devices coated thereby
CN101745144B (en) Preparation method of bone inducing porous titanium artificial bone
CN1086591C (en) Artificial joint coated with bone morphogenesis protein and its making method
KOTANI et al. Enhancement of bone bonding to bioactive ceramics by demineralized bone powder.
Kay A new concept for noncement fixation of orthopaedic devices
CN1413738A (en) Soft artificial bone material
CN111227996B (en) Outer-layer degradable medical titanium-based composite bar with bone induction and bone growth promoting activities and preparation method thereof
US20100154681A1 (en) Method for manufacturing biomedical bone filler with concrete characteristic
LeGeros et al. Calcium phosphate biomaterials: an update
Liu et al. Calcium sulfate Hemihydrate/Mineralized collagen for bone tissue engineering: in vitro release and in vivo bone regeneration studies
CN115252908A (en) Preparation method of composite porous titanium scaffold for increasing new bone ingrowth

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee